$The Role of AI\/ML in Medical Product Development and Regulatory Science$

The Role of AI/ML in Medical Product Development and Regulatory Science
About this Event

Click HERE to join the webinar

Join host for a discussion on the evolving role of Artificial Intelligence and Machine Learning in the development of medical products and how these technologies intersect with regulatory science.

Helfgott will discuss how AI/ML is shaping drug and device development, clinical trials, and the regulatory review process. The session will provide insights into both the current applications and future potential of AI/ML within the regulatory landscape, with a focus on challenges and opportunities for industry stakeholders.

Jonathan Helfgott is a Senior Lecturer and Program Coordinator at Johns Hopkins University in the MS in Regulatory Science program. Outside of Johns Hopkins, Helfgott is the executive director of global regulatory/clinical affairs and market access at Stage 2 Innovations. Prior to joining Stage 2 Innovations, Helfgott was the associate director for risk science within the Office of Scientific Investigations at FDA’s Center for Drug Evaluation & Research.